Orthofix Medical (OFIX) Income from Continuing Operations (2010 - 2026)
Orthofix Medical's (OFIX) quarterly Income from Continuing Operations came in at 20908000.0 in Q1 2026, up 60.62% YoY from 13016995.22 in Q1 2025, and down 1734.04% on a QoQ basis from 1140000.0 in Q4 2025.
Orthofix Medical (OFIX) Income from Continuing Operations (2010 - 2026) Analysis & Trends
Orthofix Medical (OFIX) has 17 years of Income from Continuing Operations data on file, last reported at 20908000.0 in Q1 2026.
- Quarterly Income from Continuing Operations rose 60.62% year-over-year to 20908000.0 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was 41237000.0 (up 70.79% YoY) and the FY2025 annual result came in at 91110000.0, up 26.59% from the prior year.
- Income from Continuing Operations eased to 20908000.0 in Q1 2026, from 1140000.0 in the prior quarter.
- In the past five years, Income from Continuing Operations ranged from a high of 3606000.0 in Q2 2025 to a low of 60938000.0 in Q1 2023.
- A 5-year average of 19449235.29 and a median of 20908000.0 in 2026 frame the typical range for Income from Continuing Operations.
- The widest YoY moves for Income from Continuing Operations: up 110.78% in 2025, down 24255.05% in 2025.
- Tracing OFIX's Income from Continuing Operations over 5 years: stood at 5844000.0 in 2022, then tumbled by 279.43% to 22174000.0 in 2023, then slipped by 22.95% to 27263000.0 in 2024, then surged by 95.82% to 1140000.0 in 2025, then sank by 1734.04% to 20908000.0 in 2026.
- The last three Income from Continuing Operations figures came in at 20908000.0 (Q1 2026), 1140000.0 (Q4 2025), and 22795000.0 (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Income (Continuing) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 200.20 Bn | 194.60 Bn | 7.27 Bn | 928.00 Mn |
| 2 | Stryker | 129.69 Bn | 126.21 Bn | 4.50 Bn | 1.28 Bn |
| 3 | Medtronic | 120.14 Bn | 110.92 Bn | 6.41 Bn | 1.26 Bn |
| 4 | Boston Scientific | 74.16 Bn | 73.62 Bn | 3.85 Bn | 905.00 Mn |
| 5 | Edwards Lifesciences | 52.68 Bn | 48.43 Bn | 1.35 Bn | 241.40 Mn |
| 6 | Dexcom | 34.57 Bn | 32.62 Bn | 830.00 Mn | 249.10 Mn |
| 7 | GE HealthCare Technologies | 34.09 Bn | 31.98 Bn | 2.18 Bn | 574.00 Mn |
| 8 | Koninklijke Philips | 26.49 Bn | 23.17 Bn | 4.55 Bn | 1.04 Bn |
| 9 | Steris | 23.19 Bn | 22.70 Bn | 684.20 Mn | 201.00 Mn |
| 10 | Orthofix Medical | 418.88 Mn | 314.47 Mn | 149.71 Mn | -15.80 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | -15.80 Mn |
| Mar 31, 2026 | -20.91 Mn |
| Dec 31, 2025 | -1.14 Mn |
| Sep 30, 2025 | -22.80 Mn |
| Jun 30, 2025 | 3.61 Mn |
| Mar 31, 2025 | -53.09 Mn |
| Dec 31, 2024 | -27.26 Mn |
| Sep 30, 2024 | -27.39 Mn |
| Jun 30, 2024 | -33.44 Mn |
| Mar 31, 2024 | -218,000.00 |
| Dec 31, 2023 | -22.17 Mn |
| Sep 30, 2023 | -2.22 Mn |
| Jun 30, 2023 | -39.43 Mn |
| Mar 31, 2023 | -60.94 Mn |
| Dec 31, 2022 | -5.84 Mn |
| Sep 30, 2022 | -10.72 Mn |
| Jun 30, 2022 | -2.21 Mn |
| Mar 31, 2022 | -4.46 Mn |
| Dec 31, 2021 | -812,000.00 |
| Sep 30, 2021 | -334,000.00 |